EC Clinical and Medical Case Reports

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children occurring most commonly in the head and neck region. The treatment involves using a multimodality approach including chemotherapy, surgery and radiation therapy. Survival for patients with localized disease has improved markedly, but the treatment of advanced disease remains a challenge.

 Keywords: Rhabdomyosarcoma; Child; Scan

1. Sangkhathat S. “Current management of pediatric soft tissue sarcomas”. World Journal of Clinical Pediatrics 4 (2015): 94‐105.
2. Arndt CA and Crist WM. “Common musculoskeletal tumors of childhood and adolescence”. New England Journal of Medicine 5 (1999): 342‐352.
3. Ognjanovic S., et al. “Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005”. Cancer 18 (2009): 4218‐4226.
4. Miwa S., et al. “Recent advances and challenges in the treatment of rhabdomyosarcoma”. Cancers (Basel)7 (2020): 1758.
5. Christophe Bergeron., et al. “Actualités sur le rhabdomyosarcome chez l'enfant”. Bulletin de Cancer1 (2002): 108-112.
6. Rodary C., et al. “A report of common criteria in childhood rhabdomyosarcoma”. Journal of Clinical Oncology 6 (1987): 324-325.
7. Shern JF., et al. “Pediatric rhabdomyosarcoma”. Critical Reviews in Oncogenesis 3-4 (2015): 227‐243.
8. Radzikowska J., et al. “Management of pediatric head and neck rhabdomyosarcoma: a case‐series of 36 patients”. Oncology Letters 5 (2016): 3555‐3562.
9. Arndt CA. “Risk stratification of rhabdomyosarcoma: a moving target”. American Society of Clinical Oncology Educational Book 33 (2013): 415‐419.
10. Gartrell J and Pappo A. “Recent advances in understanding and managing pediatric rhabdomyosarcoma”. F1000Research 9 (2020): 685.